CPI, the Cell and Gene Therapy Catapult and MicrofluidX announce development of technology to rapidly scale up cell and gene therapy manufacture

Written By Charlotte Kirby
Charlotte Kirby
Previous

Spotta’s smart pest systems attracts $1.18m seed funding from US and UK
Next

Thought Machine raises an extra $42m to bring Series B funding round to $125m